Payal Dhar - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Payal Dhar

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Biomedicines|January 23, 2024

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent ModesAnthony V Serritella, Pablo Saenz-Lopez Larrocha, Payal Dhar, et al.

Natural Product Research|July 28, 2015

Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariaeDimple R Bhatia, Payal Dhar, Varun Mutalik, et al.

Communications Biology|July 23, 2021

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.

Journal of Medicinal Chemistry|April 29, 2025

Antibody-Drug Conjugates of NLRP3 Agonists: How Overcoming Lysosomal Accumulation Necessitated Noncanonical Linker AttachmentsPaul S Riehl, Meng Yao Zhang, Payal Dhar, et al.

ACS Medicinal Chemistry Letters|January 15, 2025

Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate ApproachYam B Poudel, Julian C Lo, Derek J Norris, et al.

Cell Metabolism|November 14, 2017

CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Biomedicines|January 23, 2024

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent ModesAnthony V Serritella, Pablo Saenz-Lopez Larrocha, Payal Dhar, et al.

Natural Product Research|July 28, 2015

Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariaeDimple R Bhatia, Payal Dhar, Varun Mutalik, et al.

Communications Biology|July 23, 2021

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.

Journal of Medicinal Chemistry|April 29, 2025

Antibody-Drug Conjugates of NLRP3 Agonists: How Overcoming Lysosomal Accumulation Necessitated Noncanonical Linker AttachmentsPaul S Riehl, Meng Yao Zhang, Payal Dhar, et al.

ACS Medicinal Chemistry Letters|January 15, 2025

Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate ApproachYam B Poudel, Julian C Lo, Derek J Norris, et al.

Cell Metabolism|November 14, 2017

CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.

Pageof 2